Top Banner
Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square, London WC1N 3BG The Medical and Surgical Treatment of Epilepsy
37

Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

Dec 25, 2015

Download

Documents

Deirdre Lucas
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

Professor Ley SanderDepartment of Clinical and Experimental Epilepsy

UCL Institute of Neurology

National Hospital for Neurology & Neurosurgery

Queen Square, London WC1N 3BG

The Medical and Surgical Treatment of Epilepsy

Page 2: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

The Treatment of Epilepsy

• The incidence and prevalence

• Aetiologies and risk factors

• Aims of treatment

• Clinical settings

• Principles of treatment – Medical treatment– Surgical treatment

• Guidelines

• Conclusions

Page 3: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

Incidence and Prevalence

• Incidence of new cases of epilepsy:• 50/100,000/year

• Incidence of single seizures:• 20 - 30/100,000/year

• Prevalence of active epilepsy • 5 - 10/1,000 (50% because on AEDs)

• Severe epilepsy: 1 - 2/1,000

• Cumulative Incidence (lifetime prevalence):• 2 - 5%

Page 4: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

Incidence and Prevalence in the UK

• 30 000 new cases a year

• 300 000 - 400 000 cases

• 72 000 - 80 000 cases of severe epilepsy

Page 5: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

Incidence and Prevalence in the UK

• GP– 1 - 2 new cases of epilepsy/year– 10 - 12 cases of active epilepsy

• Neurologist– 150 cases of epilepsy/single seizures/year– 1,200 cases of active epilepsy

Page 6: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

Epilepsy: Aetiologies and Risk Factors

• Risk factors varies with age and geographic location

– Congenital, developmental and genetic conditions in childhood, adolescence and young adults

– Head trauma, infection and tumours at any age although tumours more likely over age 40

– Cerebrovascular disease common in elderly

– Endemic infections are associated with epilepsy in certain areas – malaria, neurocysticercosis, paragonomiasis,

– no adequate large scale study of attributable risk yet

Page 7: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

Antiepileptic Treatment

• AEDs are mainstay treatment

• Non-pharmacological options feasible in only few selected cases

– Surgery

• Curative

• Palliative

– Ketogenic diet (children)

– Behaviour modification– Avoidance therapy in cases with clear precipitants

Page 8: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

Aims of Antiepileptic Treatment

• Complete seizure freedom• 50% seizure reduction of little benefit

• No adverse effects• long term treatment - long term effects ?• cognitive effects debilitating• teratogenicity

• Non-obtrusive treatment• once or twice daily• No PK or PD interactions

• Maintenance of a normal lifestyle

• Reduction in morbidity and mortality

Page 9: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

AED Treatment: Clinical Settings

• Prophylactic Treatment

• Newly Diagnosed Epilepsy

• Single seizure

• Recurrent seizures

• Chronic Epilepsy

Page 10: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

Prophylactic use of AEDs

• Often advocated after • Head injury• Craniotomy

There are considerable compliance problems

• There is no evidence of a protective effect of this policy• No place for this!

• Better wait for the event to happen

Page 11: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

Is it Epilepsy ?

• Newly diagnosed or suspected cases at Primary Care

level > 50% not epilepsy

commonest differential diagnosis: syncope

• Chronic cases 15 - 20% not epilepsy

mostly psychological in nature

Careful diagnostic assessment a must in all cases

Page 12: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

The Single Seizure

• A controversial area!

• Single unprovoked attack usually not treated: practice to defer treatment until 2 or more seizures, although patients at high risk may be treated after a first attack

• Incidence of epilepsy much greater than of single seizures

• Community-based studies show that overall risk of a second

seizure greater than previously accepted • selection bias

Patients Seizure type

time to entry bias

Page 13: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

The Single Seizure

• AED treatment following a single seizure reduce risk of recurrence in the short term although long term prognosis not changed

• This may eventually lead to changes in the way single seizures are managed• treatment after first seizure• - for six months, for a year?

• tailored treatment and not symptomatic

• Meanwhile, involve patient and or guardians in the decision

Page 14: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

Recurrent Seizures

• Treatment recommended after two or more seizures

Exceptions:

- Long interval between seizures

- Clear identifiable precipitant factor

- Patient against treatment

- Unlikely compliance

Page 15: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

Precipitating Factors

Fever

Drugs

Alcohol

Photo-Sensitivity

Sleep Deprivation

Reflex Mechanisms

Acute Metabolic Stress

Emotional Stress/Major Life Events

Page 16: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

Starting an AED

• Starting AED treatment is a major event and should not be undertaken without careful evaluation of all relevant factors

• Therapy is a long term prospect

• All implications must be fully explained to the individual and or guardian

• Paramount that the patient or guardians are kept informed about the treatment process and the rationale behind it

Page 17: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

Starting Treatment

• Treatment should always be started with a single drug at a small dose

• All common side-effects must be discussed• teratogenicity and contraception if applicable

• Importance of compliance should be stressed

• Careful titration is a must

- start low, go slow

Page 18: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

Choice of AEDs treatment

• Choice of AED influenced by:• Type of seizure and or epileptic syndrome • Individual circumstances of patient• Side effect profile of drug• Personal preferences

• No clear cut evidence based medicine is available!

• Clinical practice is based more on dogmatic teaching than on scientific knowledge

• Empirical rather than rational

Page 19: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

Principles of AED treatment

• Diagnosis clearly established

• Appropriate first line drug for syndrome and patient

• One drug at a time as a rule:– If first drug ineffective add another first line drug and then

withdraw first drug

• Combination therapy only when single drug ineffective

Page 20: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

What Is Chronic Epilepsy ?

• Active 2 years after onset

• Failed 2 first line AEDs

• Great number of seizure in early history

Page 21: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

Chronic Epilepsy 1

• Review history of epilepsy- Obtain and review old notes if possible- Interview patient and witness- Classify seizures

• Review diagnosis- Non-epileptic events- Identifiable aetiology- High resolution MRI scanning

• Question Compliance- Check serum AED levels

• Review past and present AED treatment for efficacy and side-effects

Page 22: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

Chronic Epilepsy 2

• Select the AED that is most likely to be efficacious and with the least side-effects

• Adjust the dose of the selected drug to the optimum

• Attempt to reduce and taper other AEDs

• If seizures continue despite a maximally tolerated dose of a first-line drug: - Check compliance- tablet count, serum levels, counselling

• Commence another first-line AED if there is one that has not been used to its optimum

Page 23: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

Chronic Epilepsy 3

• If seizures continue try a combination of two AEDs

• If combination unhelpful, AED which appears most effective and with fewer side-effects should be continued and the other AED replaced

• If this drug is effective, withdrawal of the initial agent should be considered; if not, it should be replaced by another AED

• Consider the possibility of surgical treatment

• Consider using an experimental AED

Page 24: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

Inappropriate use of AEDs

• Inappropriate treatment of people who do not have epilepsy

• Inappropriate drug treatment of patients who do have epilepsy• JME easily treated with some AEDs but poorly controlled with others• Partial epilepsies often misdiagnosed as generalised epilepsy

• Incorrect dosages or inappropriate use of polytherapy • Overzealous adherance to “therapeutic” AED drug levels

Page 25: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

AED drug levels monitoring

Measurement of AED levels: • drug toxicity occurs and needs to be documented• suspected non-compliance• suspected drug interactions• during pregnancy (free levels)• during systemic illness• phenytoin therapy

Not a guide to dosing!

Page 26: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

• Partial seizures: simple, complex, sec gen.

• Stereotyped onset

• No non-epileptic attacks

• No contraindication for Neurosurgery

• Active epilepsy for >2-3 yr, despite 3 + AEDs

• Inadequate seizure control: > 1-2 c p s /month

• Acceptance of best risk / benefit ratio

Who Should be Evaluated for Surgery

Page 27: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

Best risk vs benefit ratio of temporal lobe epilepsy surgery

Medical Surgical

Chance of seizure control 10% 70%

Risk Morbidity from seizures 1/100 long-lasting impairment Psychosocial handicap hemiparesis, aphasia 1/100 Annual mortality 1/20 quandrantanopia prevents

driving

Page 28: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

• 70% Anterior temporal lobe resection

• 20% Extra-temporal cortical resection Lesionectomy

• 10% Palliative Procedures • Hemispherectomy• Corpus callosotomy• Subpial transection• Vagal Nerve Stimulation

Range of Epilepsy Surgery

Page 29: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

Convergence of data– One epileptogenic & dysfunctional area – Rest of brain normal

• Clinical• Neuro-Imaging• EEG• Neuropsychology• Neuropsychiatry • Psychosocial

Components of Presurgical Evaluation

Page 30: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

Realistic expectations?• Improvement in life from seizure control? • Intelligence, memory will not improve• Not more attractive, employable• Need to continue AEDs after Social support• Family, friends, community, finances

Psychosocial

Page 31: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

• Fundamental

• MRI predicts nature and extent of pathology

• Unusual to resect area with normal imaging

• Poor results if imaging normal

Neuro-imaging

Page 32: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

TLE: Anterior Temporal Lobe resection • Focal pathology: 70% seizure free, 25% >90% reduced

• DNT, cavernoma>HS>AVM>trauma>MCD

• 20% seizure free if no focal pathology

Extra Temporal Lobe• Focal pathology: 60% seizure free, 20% >90% reduced

• DNT, cavernoma, glioma>AVM>trauma

• MCD 20-30% seizure free, if focal

• <20% seizure free if no focal pathology

Pathology and Outcome

Page 33: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

Treatment Guidelines for Epilepsy

• NICE = www.nice.org.uk – National Institute for Clinical Excellence (England and Wales)

• SIGN = www.sign.ac.uk – Scottish Intercollegiate Guidelines Network (Scotland)

• AAN = www.aan.com – American Academy of Neurology (USA)

Page 34: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

Primary Care Guidelines for Epilepsy

• Referral of ALL who experience a suspected seizure– Seen within 14 days by specialist

• Risk and safety precautions documented• Care Plan in place• At least a yearly review• Early re-referral if

– Treatment failure– Seizures not controlled– Diagnostic uncertainty – Considering pregnancy– Considering drug withdrawal

Page 35: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

Managing People With Epilepsy

Holistic issues:- Interest and continuity of care- Clear plan- Information provision

- SUDEP

- Easy access

- Practical Issues: • Cooking, Bathing, Driving, Contraception, Conception

- Reasonable Expectations:• Prognosis, Independent Living, Employment

Page 36: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

AED Treatment: Conclusions

Correct diagnosis and classification paramount to treatment

AEDs are mainstay treatment

Treatment empirical rather than rational!

> 70% of patients become seizure free

Potential complications: toxicity

Low threshold for s/effects

Page 37: Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square,

AED Treatment: Conclusions

Potential for misuse of AEDs not to be dismissed

New AEDs may be better tolerated, but more effective?

Chronic side effect profile of new AEDs not fully known

Surgical treatment very successful but only possible in a few selected cases

Consider stopping AED if seizure free for years

New treatment still needed!